These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26003773)

  • 1. Rescheduling of hydrocodone combination products: potential impact and alternatives for postoperative pain management.
    Golembiewski J
    J Perianesth Nurs; 2015 Jun; 30(3):244-8. PubMed ID: 26003773
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study.
    Fernandez J; Thornton JD; Rege S; Lewing B; Bapat S; Xu Q; Fleming ML
    J Opioid Manag; 2018; 14(5):317-326. PubMed ID: 30387855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Enforcement Agency 2014 Hydrocodone Rescheduling Rule and Opioid Dispensing after Surgery.
    Neuman MD; Hennessy S; Small DS; Newcomb C; Gaskins L; Brensinger CM; Wijeysundera DN; Bateman BT; Wunsch H
    Anesthesiology; 2020 May; 132(5):1151-1164. PubMed ID: 32101973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin has opioid-sparing effects following augmentation mammaplasty.
    Freedman BM; O'Hara E
    Aesthet Surg J; 2008; 28(4):421-4. PubMed ID: 19083556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ibuprofen-hydrocodone for the treatment of postoperative pain after periodontal surgery.
    Betancourt JW; Kupp LI; Jasper SJ; Farooqi OA
    J Periodontol; 2004 Jun; 75(6):872-6. PubMed ID: 15295955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of the efficacy of scheduled dosing of acetaminophen and hydrocodone for the management of postoperative pain in children after tonsillectomy.
    Gurnaney H; Ganesh A
    Clin J Pain; 2011 Jan; 27(1):89; author reply 90-1. PubMed ID: 21150706
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain.
    Bartoli A; Michna E; He E; Wen W
    Postgrad Med; 2015 Jan; 127(1):5-12. PubMed ID: 25526227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcotic analgesics for dental pain: available products, strengths, and formulations.
    Wynn RL
    Gen Dent; 2001; 49(2):126-8, 130, 132 passim. PubMed ID: 12004688
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrate.
    Argoff C; Arnstein P; Stanos S; Robinson CY; Galer BS; Gould E; Gammaitoni A
    J Opioid Manag; 2015; 11(5):417-24. PubMed ID: 26535969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescheduling of combination hydrocodone products: problems for long-term care practitioners.
    Mattingly Ii TJ
    Consult Pharm; 2015 Jan; 30(1):13-9. PubMed ID: 25591027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of multimodal analgesic treatment after laparoscopic appendectomy in children.
    Liu Y; Seipel C; Lopez ME; Nuchtern JG; Brandt ML; Fallon SC; Manyang PA; Tjia IM; Baijal RG; Watcha MF
    Paediatr Anaesth; 2013 Dec; 23(12):1187-92. PubMed ID: 24112856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of hydrocodone/acetaminophen combination product in children ages 6-17 with moderate to moderately severe postoperative pain.
    Liu W; Dutta S; Kearns G; Awni W; Neville KA
    J Clin Pharmacol; 2015 Feb; 55(2):204-11. PubMed ID: 25196888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocodone extended-release: pharmacodynamics, pharmacokinetics and behavioral pharmacology of a controversy.
    Gould HJ; Paul D
    Pharmacol Res; 2015 Jan; 91():99-103. PubMed ID: 25301538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain.
    Hale ME; Zimmerman TR; Ma Y; Malamut R
    J Opioid Manag; 2015; 11(5):425-34. PubMed ID: 26535970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release hydrocodone (Zohydro) for pain.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):45-6. PubMed ID: 24933087
    [No Abstract]   [Full Text] [Related]  

  • 17. Better late than never: time to up-schedule hydrocodone combination products.
    Kolodny A
    Pain Med; 2013 Nov; 14(11):1627-8. PubMed ID: 24238352
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management.
    Singla A; Sloan P
    J Opioid Manag; 2013; 9(1):71-80. PubMed ID: 23709306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA committee: More restrictions needed on hydrocodone combination products.
    Kuehn BM
    JAMA; 2013 Mar; 309(9):862. PubMed ID: 23462764
    [No Abstract]   [Full Text] [Related]  

  • 20. Perioperative management of patients taking treatment for chronic pain.
    Farrell C; McConaghy P
    BMJ; 2012 Jul; 345():e4148. PubMed ID: 22761087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.